Biosensor-regulated gene therapy reduces heart attack damage in mice
A novel gene therapy that responds specifically to oxygen-starved heart muscle may protect against further injury following a heart attack, a study by University of South Florida cardiovascular researchers found.
Their findings are reported in the April 2004 issue of the journal Hypertension.
M. Ian Phillips, PhD, DSc, and his team at the USF College of Medicine and All Childrens Hospital Research Institute designed a kind of oxygen-sensitive biosensor that turns on protective genes when signs of oxygen deprivation indicate a heart attack and turns the genes off once blood flow restores adequate oxygen levels to the heart. Dr. Phillips, principal investigator; Yao Liang Tang, MD, lead author; and colleagues showed that this biosensor-regulated gene therapy protected heart muscle cells in mice with heart attacks from further injury.
Dr. Phillips and Dr. Tang envision administering such a therapy after a first heart attack to limit initial damage and prevent future attacks. While much work remains to test and refine such a therapy, Dr. Phillips said, this new concept might eventually be an alternative to stents and bypass surgery.
People who suffer one heart attack are at higher risk for subsequent attacks. Often lack of blood flow to the heart muscle, known as cardiac ischemia, does not cause pain or other symptoms. This asymptomatic or "silent" ischemia can lead to a second or third heart attack without prior warning.
"Repeated bouts of myocardial ischemia cause cumulative tissue damage in the heart vessels that can lead to a fatal heart attack," said Dr. Phillips, USF vice president for research and professor of physiology and biophysics. "Therefore, what patients need is a gene therapy strategy that acts in the heart and switches on or off, so that the therapeutic protein is produced only where and when it is needed."
"One of the exciting aspects of the approach, described by Tang et al, is the ability to directly link expression of potentially therapeutic genes to a pathological stimulus associated with myocardial infarction, ischemia," states an editorial in Hypertension highlighting the USF research. "Ultimately, this area of research will pave the way for development of smart therapies for the heart that allow for early and rapid treatment of a wide variety of cardiac ailments."
The USF researchers designed a molecule -- which they call a "vigilant vector" -- containing both a means to increase the expression of protective heme oxygenase-1(HO-1) genes and the oxygen-sensitive switch that turns these genes on and off. They injected this molecule directly into the hearts of mice one hour after the mice had heart attacks.
Ten days following their heart attacks, the mice that received the biosensor-regulated gene therapy showed less heart tissue scarring and better recovery of heart pumping function than the untreated mice injected with saline only. The researchers demonstrated that turning on the protective HO-1 genes stopped the heart muscle cells from dying and limited the area of damage.
Anne DeLotto Baier | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
New success for Konstanz physicists in studying the quantum vacuum
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...